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 CLINICAL AND SYSTEMATIC REVIEWS 
 INTRODUCTION 
 The defi nition of NCWS 
 In the last 5 years since the publication of the very stimulating 
article by Elena Verd ù about patients with irritable bowel syn-
drome-like (IBS-like) symptoms who fully resolve their symp-
toms on gluten-free diet even though they do not fulfill the 
diagnostic criteria for celiac disease (CD) or wheat allergy ( 1 ), 
there has been scientific interest in a possibly new clinical con-
dition, which has been called a  “ fertile crescent for research ” 
( 2 ). This condition was initially named  “ gluten sensitivity ” 
( 3,4 ), but subsequently the term  “ non-celiac gluten sensitivity ” 
( 5 ) was preferred to better distinguish it from CD. However, it 
is not known which components of wheat cause the symptoms 
in non-celiac gluten sensitivity patients, and because there is 
no definite proof that gluten is really the culprit ( 6 ), we prefer 
the term  “ non-celiac wheat sensitivity ” (NCWS) ( 7 ).  
 The spectrum of NCWS symptoms 
 Many gastrointestinal and extra-gastrointestinal symptoms have 
been attributed to NCWS.  Table 1 summarizes the clinical symp-
toms reported in the literature and those which we have observed 
in our patients ( 4,7 – 10 ). Symptoms can aff ect both gastrointestinal 
and extra-gastrointestinal systems and it is probable that this list 
will change in the next few years, including new manifestations, 
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but also excluding some of those now listed. For example, although 
there is general agreement that patients suff ering from NCWS can 
have neurological manifestations, it is unknown whether some 
psychiatric symptoms (i.e., depression) can be considered a direct 
consequence of wheat ingestion or are dependent on a patient ’ s 
poor quality of life. Similarly, some patients have reported weight 
loss but it is not clear whether this is related to a malabsorption 
syndrome or self-limited diet because of fear of symptoms aft er 
meals. On the contrary, some patients report weight gain on a 
wheat-containing diet and a dramatic weight normalization aft er 
wheat exclusion from their diet. What is counterintuitive is that the 
patients subjectively report that their daily caloric intake remains 
identical or even higher. In these cases also, an accurate evaluation 
of the glycemic index of the foods consumed before and aft er the 
wheat-free diet should be mandatory, as a simple modifi cation in 
the insulin levels could be the basis of the body weight change. In 
general, it should be emphasized that such a large and heterogene-
ous list of manifestations very probably cannot have a single path-
ogenic mechanism. In this context, wheat ingestion could cause 
diff erent symptoms by diff erent mechanisms so NCWS cannot be 
considered a distinct clinical condition. In other words, NCWS 
cannot be considered  “ the sister ” of CD; that is not the proper 
model, according to our analysis. 
 To minimize possible errors in the study of the NCWS, the study 
population needs to be specifi cally defi ned and carefully grouped 
according to the clinical presentation. Th at was done in patients 
with IBS diagnosed according to the Rome II criteria ( 7 ). Th e 
results of that study and our previous clinical experience suggested 
to us that a portion of NCWS patients with IBS could be suff ering 
from non-immunoglobulin E (IgE)-mediated food hypersensitiv-
ity (FH). Th e aims of this study are: (a) to re-evaluate the results 
of the double-blind placebo-controlled (DBPC) food challenges in 
patients with IBS, underlining the results which could suggest an 
allergic pathogenesis; (b) perform a narrative review of the use of 
DBPC challenge, the role of serum immunoglobulin G (IgG) anti-
bodies, and the basophil activation assay in food allergy, and the 
histology fi ndings in the food allergy diagnosis. 
 METHODS 
 All patients included in the previous study were prescribed a 
standard elimination diet with the exclusion of wheat, cow ’ s milk 
(CM), eggs, tomato, and chocolate ( 7 ). Patients self-reporting FH 
were asked to avoid ingestion and / or contact with the food(s) caus-
ing symptoms. Aft er 4 weeks on elimination diet, they underwent 
DBPC challenges. We performed the wheat challenge by adminis-
tering a daily dose 13  g of fl our, equivalent to about 20  g of bread. 
A total of 12 capsules daily were given, three times daily, away 
from meals. DBPC challenge for CM proteins was performed with 
an identical method, administering capsules containing casein, 
lactoalbumin, and lactoglobulin, at least 4 weeks before or aft er 
wheat challenge and when the patients were asymptomatic, on 
elimination diet. Xylose was used as placebo. Th e shape and size of 
the capsules were identical in each case. Further details have been 
previously published ( 7 ). In this study, we re-evaluated the results 
of the DBPC challenges in the IBS patients included in a previous 
study ( 7 ). Th e Fisher ’ s test was used for frequency comparison; 
a  P value   <  0.05 was considered statistically signifi cant. 
 RESULTS 
 The DBPC wheat challenge in patients with IBS-like 
manifestations 
 About one-third of   >  900 patients with IBS resolved their symp-
toms on elimination diet and relapsed into symptoms on DBPC 
wheat challenge ( 7 ).  Table 2 summarizes the clinical and labora-
tory characteristics of the patients with NCWS and multiple food 
sensitivity included in that study ( 7 ), which can suggest an allergic 
background; for comparison, patients with IBS not due to food 
sensitivity (i.e., not improved on elimination diet) were selected. 
A personal history of food allergy in the pediatric age, coexist-
ent atopic diseases, positive serum anti-gliadin and anti-betalac-
toglobulin antibodies, positive cytofl uorimetric assay revealing 
 in vitro basophil activation by food antigens, and presence of 
eosinophils in the intestinal mucosa biopsies, seem strong indica-
tors of FH. Although demonstrating the existence of NCWS by 
means of the DBPC challenge method is probably the main result 
of that study, we believe it is of great interest to have revealed that 
206 of the 276 patients suff ering from NCWS showed the same 
IBS-like symptoms on CM protein DBPC challenge. Furthermore, 
the majority of those same patients showed symptoms, on open 
challenge, with egg, chocolate, and other foods. 
 DISCUSSION AND NARRATIVE REVIEW OF THE 
LITERATURE 
 Th e evidence that the majority of NCWS patients included in 
our study also exhibited CM protein hypersensitivity ( 7 ), leads 
 Table 1 .  List of the symptoms reported in patients with non-
celiac wheat sensitivity 
 Gastrointestinal 
symptoms 
 Neurological – psychiatric 
symptoms  Other symptoms 
 Abdominal pain  Foggy mind  Eczema 
 Bloating  Tiredness  Skin rash 
 Diarrhea  Headache  Joint pain 
 Constipation  Depression  Muscle pain 
 Alternating bowel 
movements 
 Numbness in arms, legs, 
and fi ngers 
 Oligo- or poly-menorrhea 
 Nausea  Hyposthenia  Anemia 
 Vomiting  Loss of balance  Weight loss 
 Hematochezia  Disturbed sleep pattern  Weight increase 
 Anal fi ssures  Mood swings  Puffi ness 
   Interstitial cystitis 
   Ingrown hairs 
 Data from the literature and our own experience. 
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choice is precisely because the AGA assay may help confi rm a 
suspicion of NCWS. Furthermore, it is of interest that Ruuskanen 
 et al. ( 18 ) showed that HLA-DQ2 – positive or HLA-DQ8 – posi-
tive subjects who were tested positive for serum AGA had more 
severe gastrointestinal symptoms than the antibody-negative sub-
jects. However, it must be emphasized that the positive predictive 
value of the AGA assay in NCWS diagnosis is very low, as it is also 
positive in 10 – 14 % of patients with IBS who do not improve on 
elimination diet ( 7 ). 
 In our hypothesis, the high levels of serum AGA, as the high 
levels of IgG anti-betalactoglobulin antibodies, could be an indi-
cator of FH, but it must be emphasized that the data on this are 
very controversial. Burks  et al. ( 19 ) examined antibody responses 
to milk proteins in patients with milk protein intolerance shown 
by oral challenge, and found no increase in IgG antibodies aft er 
positive challenge. Shek  et al. ( 20 ) concluded that food-specifi c 
IgG or IgG4 do not add any information to the food allergy 
diagnostic workup, that is, milk-induced IgE-mediated and non-
IgE-mediated disorders. In contrast, the literature suggests that 
food-specifi c IgG presence is a marker of food exposure and 
tolerance, as seen in those participating in oral immunotherapy 
studies ( 21 ). 
 Based on the above-mentioned studies, it has been affi  rmed 
that the inappropriate use of food-specifi c IgG assay might only 
increase the likelihood of false diagnoses, resulting in unnecessary 
dietary restrictions and decreased quality of life ( 22 ). As a result 
of these serious and growing concerns, the Canadian Society of 
us to suggest that a great percentage of NCWS could be cat-
egorized as being aff ected by  “ multiple FH, ” a condition, which 
is well known in the pediatric literature ( 11,12 ). In this regard, 
the fundamental role of the DBPC method must be stressed in 
the diagnosis of FH in patients with gastrointestinal manifesta-
tions. Defi nite proof of underlying immunological mechanisms 
is lacking for most gastrointestinal disorders due to food allergy, 
except for those mediated by food-specifi c IgE antibodies ( 13 ). 
However, because most gastrointestinal food allergies are not 
mediated by IgE antibodies, alternative assays in the determi-
nation of eosinophil by-products in biopsy specimens or fecal 
samples have been investigated; no such tests with acceptable 
diagnostic accuracy have been found ( 13 ). 
 Th e same considerations should apply to the diagnosis of 
NCWS. It has been clearly demonstrated that wheat can cause 
gastrointestinal symptoms in the context of FH and multiple FH. 
For example, utilizing the DBPC challenge method, we found 
that a subgroup of children with chronic constipation due to 
CM allergy ( 14 ), which did not resolve on CM-free diet, were 
suff ering from wheat hypersensitivity also, and that in these 
patients the exclusion of wheat, egg, and other foods resolved the 
symptom ( 15 ). Similar data subsequently reported that in adult 
patients with chronic constipation unresponsive to laxative treat-
ment, CM-free and wheat-free diet were eff ective in treating the 
symptoms ( 16 ). 
 Th e hypothesis that in a percentage of cases NCWS is a mani-
festation of non-IgE-mediated food allergy, is strengthened by 
the higher frequency of a history of food allergy in the pediatric 
age that we found in our cases (see  Table 2 ). Although we used 
the Fisher ’ s test instead of a multiple analysis and this could have 
determined a type 1 error, the high frequency of history of food 
allergy in the pediatric age in the adults suff ering from NCWS 
is an important datum, which we have observed in daily clinical 
practice. In this respect,  Table 3 summarizes some questions that 
we regularly pose to adult patients with suspected NCWS or FH 
(i.e., self-reported wheat-intolerant patients). We are now evalu-
ating the diagnostic accuracy of this questionnaire to propose a 
possible score. In any case, it is surely useful in daily practice to 
decide which patients have a higher probability of suff ering from 
NCWS and should be placed on an elimination diet, and whoever 
has a lower probability and should be directed to a  “ conventional ” 
treatment for IBS. 
 Obviously, the response to the elimination diet and to the sub-
sequent challenge justifi es or excludes a diagnosis of NCWS or 
multiple FH. 
 A diagnostic role for serum IgG in NCWS 
 Our data and the data of others showed that about 50 – 60 % of 
NCWS patients had elevated serum values of IgG anti-gliadin 
antibodies (AGAs) ( 7,8 ). Although the use of these antibody 
assays in CD diagnosis is advised against ( 17 ), according to this 
fi nding we think that when faced with a patient who has symp-
toms because of the consumption of gluten-containing foods, it is 
logical to test both anti-transglutaminase assay — the serum gold 
standard in reaching CD diagnosis — and anti-gliadin assay. Th is 
 Table 2 .  Clinical and laboratory data that could suggest a 
diagnosis of MFH in patients with NCWS and CMPI demonstrated 
by DBPC challenges 
 
 NCWS  +  CMPI 
( n =206) 
 IBS controls 
( n =50)  P value 
 History of food allergy in 
infancy 
 40 / 206 (19 % )  2 / 50 (4 % )  0.01 
 Coexistent atopic disease  73 / 206 (35 % )  3 / 50 (6 % )  0.0001 
 Positive serum anti-gliadin 
IgG 
 134 / 206 (65 % )  7 / 50 (14 % )  0.0001 
 Positive serum 
anti-betalactoglobulin IgG 
 80 / 206 (39 % )  7 / 50 (14 % )  0.001 
 In vitro basophil activation 
assay 
 166 / 206 (80 % )  2 / 50 (4 % )  0.0001 
 Intraepithelial eosinophil 
infi ltration in the colon 
mucosa 
 154 / 206 (75 % )  0 / 35  0.0001 
 CMPI, cow’s milk protein intolerance; DBPC, double-blind placebo-controlled; 
HPF , high-power fi eld; IBS, irritable bowel syndrome; IgG, immunoglobulin G; 
MFH, multiple food hypersensitivity; NCWS, non-celiac wheat sensitivity. 
As controls we included a group of patients with IBS not due to food intoler-
ance (from reference Carroccio  et al. ( 7 )). 
 The Fisher’s test was used for frequency comparison; a  P value   <  0.05 was 
considered statistically signifi cant. Eosinophils were counted at a HPF (40 × ); 
the presence of   >  4 eosinophils per HPF in the colon mucosa biopsy was 
considered  “ positive ” . 
The American Journal of GASTROENTEROLOGY VOLUME 108 | DECEMBER 2013   www.amjgastro.com
1848
R
E
V
IE
W
 Carroccio  et al. 
Allergy and Clinical Immunology ( 22 ), the American Academy 
of Allergy Asthma and Immunology ( 23 ), and the European 
Academy of Allergy and Clinical Immunology ( 24 ) have warned 
against the inappropriate measurement of food-specifi c IgG or 
IgG4 to suggest the presence of potential adverse food reactions. 
Recent guidelines emphasize that such testing has no role in the 
diagnosis of food allergy or intolerance ( 25 ). 
 In strong opposition to the above mentioned studies and posi-
tion papers, Zar  et al. ( 26,27 ) d emonstrated that food-specifi c 
IgG4 antibody-guided exclusion diet improves symptoms in IBS 
patients and is associated with rectal compliance improvement. 
Atkinson  et al. ( 28 ) used a double blind, randomized, controlled, 
parallel design in which IBS patients were randomized to either a 
 “ true ” diet or a  “ sham ” diet control group, based on the presence /
 absence of food-specifi c IgG antibodies to a panel of 29 diff erent 
food antigens, which showed that food elimination based on IgG 
antibodies may be eff ective in reducing IBS symptoms. Our group 
also showed a very high diagnostic accuracy of IgG anti-betalac-
toglobulin assay in pediatric patients with IBS-like ( 29 ) or gastro-
esophageal refl ux disease ( 30 ). 
 Th e assay of IgG for food antigens in the suspicion of multiple 
FH, including NCWS, should be discouraged and the elimination 
diet based on the results of these assays should not be advised. 
However, until a reliable serum marker of NCWS is found, serum 
IgG AGA could be helpful. 
 The usefulness of basophil activation assay in NCWS diagnosis 
 Th e basophil activation assay, or basophil activation test (BAT), 
is an  in vitro assessment of allergic response that requires only a 
small quantity of whole blood and allows measurement of a func-
tional response, beyond just the presence of IgE class antibody. 
Th e assay currently uses fl ow cytometry to detect upregulation, 
aft er antigen stimulation, of some activation markers (e.g., CD63 
or CD203c) usually expressed on the cell surface, in order to iden-
tify activated basophils ( 31 ). 
 BAT has been shown to be sensitive and specifi c for the diagnosis 
of IgE-mediated hypersensitivity reactions to pollens, hymenop-
tera venom, natural rubber latex allergy, and drugs ( 32 – 34 ). In 
regard to food allergy, it has been demonstrated that BAT could be 
more specifi c than skin PRICK test and / or food-specifi c IgE ( 35 ), 
and it is a reliable tool for the diagnosis of CM allergy in pediat-
ric patients, with sensitivity similar to routine diagnostic tests but 
with higher specifi city ( 36 ). 
 However, there have been very few studies on the possible 
usefulness of BAT in patients with IBS-like symptoms and sus-
pected NCWS or food-hypersensitivity. In this setting, we have 
previously shown confl icting data. In a prospective study, we 
evaluated the effi  cacy of BAT in the diagnosis of multiple FH in 
IBS-like patients ( 37 ). In this study, BAT diagnosed NCWS with 
86 % sensitivity, 88 % specifi city, and 87 % accuracy. Th is diag-
nostic accuracy can be considered excellent in a fi eld that has 
no serologic marker to aid in the diagnosis. However, the com-
mercial assay that we had used in the past changed methods, 
and since the year 2010 a new assay on whole blood replaced the 
old assay performed on separated leukocytes. Consequently, in 
our daily clinical practice we observed a fall in the accuracy of 
the assay; for this reason in a subsequent study we compared the 
 “ old ” and the  “ new ” BAT methods ( 38 ). Our results showed that 
the new BAT CD63-based detection on whole blood samples is 
not useful in FH and NCWS diag nosis. Furthermore, data from 
Ciacci  et al. do not confi rm the usefulness of BAT in NCWS 
diagnosis ( 39 ). 
 In summary, BAT accuracy in NCWS diagnosis seems exces-
sively infl uenced by a method that is not standardized and 
reproducible. Th e use of a commercial kit cannot be recom-
mended, but in each center the results of a  “ home-made assay ” 
could be compared with the results of DBPC wheat challenge 
to obtain an internal reference of BAT accuracy. Whatever is 
the real percentage of positive BAT in NCWS patients, the evi-
dence of basophil cell activation aft er wheat  in vitro challenge 
adds strength to the hypothesis of an allergic pathogenesis in a 
subgroup of NCWS. 
 Table 3 .  Questions which, in our experience, can be useful to 
pose to the patients with suspected NCWS or MFH 
 Questions  Comments 
 Did you suffer from food allergy in 
infancy?  
 If yes: how was the diagnosis was 
made:  
 DBPC challenge? Open challenge? 
IgE-based assays? 
 A history of food allergy in infancy 
is more frequent in NCWS patients 
than in IBS patients. 
 If you don ’ t know whether you 
suffered from food allergy or not: 
did you change the kind of milk in 
infancy? Did you have a pediatric 
history of  “ milk intolerance ” ? Did 
you have problems at the time of 
weaning? 
 If yes: although quite vague, these 
elements can suggest a possible 
condition of cow’s milk protein 
hypersensitivity in infancy or of 
wheat / multiple food hypersensitivity. 
 In patients with IBS-constipation: 
have you suffered from chronic 
constipation since infancy and the 
pediatric age? 
 Chronic constipation with poor 
response to laxative treatment, 
in the pediatric age, is often an 
unrecognized sign of food hyper-
sensitivity. 
 Have you suffered (or are suffering) 
from allergic rhinitis or conjuncti-
vitis or bronchial asthma or atopic 
dermatitis? 
 Previous history or coexistence 
of atopic diseases increase the 
probability of NCWS or multiple 
food hypersensitivity. 
 Did you suffer from umbilical ery-
thema (presence of erythematous 
skin in the umbilical and periumbili-
cal region, with or without secretion) 
in the pediatric age, or are you 
suffering from it now? 
 The skin in the umbilical area can 
be affected by localized dermatitis 
and may be a sign of food allergy. 
 Did you suffer from perianal 
erythema (presence of erythema-
tous skin in the anal and perianal 
region) in the pediatric age, or are 
you suffering from it now? 
 The skin in the perianal area can be 
affected by localized dermatitis and 
may be a sign of food allergy. 
 DBPC, double-blind placebo-controlled; IBS, irritable bowel syndrome; 
MFH, multiple food hypersensitivity; NCWS, non-celiac wheat sensitivity. 
 A positive response increases the probability of a correct diagnosis of NCWS 
or MFH. 
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Marsh 1 histology in 33 of 78 (42 % ) cases. Our recent retro-
spective study ( 7 ) showed a duodenal mucosa IEL increase (  >  25 
IEL / enterocytes) in 248 of 276 cases (90 % ). In our study ( 7 ), as 
in that of Sapone  et al. ( 44 ), the entity of IEL infi ltration was 
intermediate between those observed in patients with CD and in 
controls with  “ functional ” gastrointestinal disorders (dyspepsia 
or IBS). However, IEL infi ltration of the duodenal mucosa can 
be due to several causes ( 45 ), so it is not possible to consider this 
fi nding specifi c of wheat sensitivity. 
 A more plausible histology marker of NCWS suggested by 
our experience is the mucosal eosinophil infi ltrate. Colon his-
tology evaluation showed intraepithelial and lamina propria 
infi ltration of eosinophils in about two-thirds of cases and this 
fi nding was also frequently observed in the duodenum ( 7 ). We 
found   >  4 intraepithelial eosinophils (at a high-power fi eld: 40 × ) 
in the colon mucosa in 174 of 276 (63 % ) NCWS patients; fur-
thermore, the count of the duodenal intraepithelial eosinophils 
was signifi cantly higher in NCWS patients than in IBS controls 
( 7 ). In an experimental model, it has been shown that oral anti-
gen can induce eosinophilic infl ammation in various segments 
of the gastrointestinal tract, including the esophagus, stomach, 
small intestine, and Peyer ’ s patches ( 46 ). It is known that both 
the mixed IgE-mediated and non-IgE-mediated diseases com-
prise distinct hypersensitivity disorders that are characterized by 
a pronounced eosinophil infi ltration of the gastrointestinal tract 
and have been referred to as eosinophil-associated gastrointes-
tinal disorders ( 47 ). 
 In several previous studies, we found that the eosinophil 
infiltrate in the intestinal mucosa characterized the patients 
suffering from chronic constipation due to food allergy ( 12,13 ). 
Similar histological data were reported in school-age children 
with rectal bleeding due to allergic procto-colitis ( 48 ). It is 
also interesting that in 70 of 206 (35 % ) patients with NCWS 
and CM protein hypersensitivity, we found the presence of 
lymphoid hyperplasia in the colon mucosa ( 7 ). This histology 
characteristic has been reported in adult patients ( 49 ) and chil-
dren ( 50 ) with rectal bleeding due to food allergy. In clinical 
practice, the eosinophil infiltrate and / or the presence of lym-
phoid hyperplasia in the colon or duodenal mucosa cannot be 
considered an accurate diagnostic marker of NCWS. However, 
their presence could recommend an elimination diet; the clini-
cal response to the diet and the subsequent DBPC challenge 
confirm the diagnosis. 
 Alternative and supplementary hypotheses 
 Although we have shown several aspects that could indicate an 
allergic condition at the basis of the functional bowel disease 
in NCWS patients, it is very probable that diff erent pathogenic 
mechanisms are responsible for IBS-like symptoms in diff erent 
subgroups of patients or even in the same patient. 
 First, some proteins in wheat are difficult to digest as the 
human intestine physiologically lacks the enzymes, which 
should cut the protein chains into single amino acids. Residual 
long peptides could have a role in causing functional diges-
tive problems. Furthermore, it is becoming more difficult to 
 The association between NCWS and atopic diseases 
 In regard to a possible association between NCWS and atopic 
diseases, Massari  et al. ( 40 ) found a very high frequency (29 % ) 
of duodenal mucosa lesions in patients with atopic diseases 
(asthma, rhinitis, or contact dermatitis); all patients were nega-
tive for CD-specifi c serum antibodies (endomysial antibodies) 
and showed gastrointestinal problems, which disappeared on 
gluten-free diet and the authors concluded that NCWS com-
monly occurs in allergic patients. Although some limitations of 
the study must be noted, that is, patients with intestinal villi atro-
phy were included — the frequency of the association reported by 
the authors is surprising. 
 Th e other side of this relationship was shown in our recent 
study ( 7 ). We found that 73 of 206 patients suff ering from NCWS 
associated with CM protein hypersensitivity showed coexist-
ent atopic diseases: a frequency signifi cantly higher than that 
observed in patients suff ering from IBS. In general, the relation-
ship between FH and atopic manifestations, although investi-
gated in patient-based studies, has been scarcely evaluated in the 
general population. 
 According to a recent study of the Centers for Disease Control 
and Prevention, children with food allergy are about 2 – 4 times 
more susceptible to develop further clinical manifestations, 
such as respiratory allergies (3.6-fold), asthma (4.0-fold), and 
atopic dermatitis (2.4-fold), compared with children without 
food allergy ( 41 ). Several studies reported the co-occurrence 
of other allergic conditions in adult patients with food allergy, 
such as: asthma (34 – 49 % ), allergic rhinitis (33 – 40 % ), and atopic 
dermatitis (35 – 71 % ) ( 42,43 ). However, it must be said that the 
above studies ( 41 – 43 ) referred to patients with IgE-mediated 
food allergy, a condition that — by defi nition — excludes NCWS. 
In general, the preliminary data that seem to indicate a higher 
frequency of atopic diseases in NCWS patients and NCWS in 
atopic patients support the hypothesis that a subgroup of NCWS 
patients suff er from non-IgE-mediated food allergy. 
 Histology in NCWS: elements that can support the food allergy 
hypothesis 
 Duodenal histology in NCWS patients has been evaluated. 
Villous atrophy has never been reported, although it is a tauto-
logical fi nding because in the presence of villous atrophy NCWS 
diagnosis is excluded by defi nition ( 4 ). In our experience, there 
are very few patients who could be included in the diagnostic 
category of  “ NCWS plus CM protein hypersensitivity ” and who 
showed mild-to-moderate duodenal villous atrophy (unpublished 
data). Obviously, we are referring to patients who did not display 
DQ2 and DQ8 alleles. Owing to the need to explore NCWS while 
avoiding further confounding elements, we agree that the doubt-
ful cases, that is, those showing intestinal villi damage, must be 
excluded. 
 Consequently, the duodenal histology of NCWS is reported 
as normal (Marsh 0) or characterized by an infi ltration of 
intraepithelial lymphocytes (IELs; Marsh 1), in absence of villi 
atrophy. Sapone  et al. ( 44 ) reported   >  30 IEL / 100 enterocytes in 
22 of 26  “ gluten-sensitive patients ” , and Volta  et al. ( 8 ) found 
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with HLA-DQ8 – bound gluten peptides; HLA-DQ6 controls did 
not exhibit the abnormalities in gut function observed in DQ8 
mice. Th e authors concluded that gluten sensitivity in HLA-DQ8 
mice can induce immune activation in the absence of intestinal 
atrophy. It could be of interest to connect the above results with 
our recent data showing an elevated anal sphincter pressure due 
to wheat and CM -hypersensitivity in patients with anal fi ssures 
( 61 ). In these patients, a wheat-free diet led to a reduction in anal 
sphincter pressure and a high rate of anal fi ssure healing. 
 Recently, there was further evidence that HLA-DQ2 / DQ8 –
 positive patients suff ering from diarrhea-predominant IBS 
showed higher small bowel and colon permeability on a diet con-
taining gluten than on a diet containing rice. Th ese patients also 
showed signifi cant decreases in expression of zonula occludens 1, 
claudin-1, and occludin in rectosigmoid mucosa on the gluten-
containing diet. On the whole, these data confi rmed that gluten 
alters the bowel barrier functions in patients with IBS-diarrhea, 
particularly in HLA-DQ2 / DQ8 – positive patients ( 62 ). 
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* AGA IgG +ve
* BAT positivity
* Coexistent atopy
* History of food
allergy in infancy
* Normal histology
* Symptoms
resolution on low
FODMAP diet
* HLA DQ2 +
* Increased IEL CD3+
* Positive EmA in
culture medium
* Family history of CD
Allergy-like
FODMAP effect
Psychological factors
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hypersensitivity
* No mucosal
inflammation
* Depression/anxiety Change of
microbiota
OTHER??
CD-like
 Figure 1 .  NCWS patients. Hypotheses of different subgroups of NCWS 
patients, according to different pathogenic mechanisms. Patients in the 
upper side of the fi gure (CD-like) have clinical and laboratory characteris-
tics, which resemble CD, although they do not fulfi ll the current diagnostic 
criteria for CD; it is probable that they can develop CD in the future. Patients 
on the right side of the fi gure (allergy-like) show clinical laboratory character-
istics, which resemble food allergy; this group is, in our experience, the most 
numerous. Patients on the lower side of the fi gure show no signs of duode-
nal histology infl ammation and benefi t from a low FODMAP diet — they could 
not be considered as really affected by NCWS. Patients on the left side of the 
fi gure are those with  “ typical IBS ” related to psychosomatic mechanisms: 
in these patients NCWS could be excluded by means of DBPC challenge. 
The middle of the fi gure underlines the possible role of the microbiota and 
the change that a restricted diet (i.e., gluten free) can cause in the intestinal 
fl ora. This could be a key element to understand the effect of the dietary 
change on intestinal symptoms. Other factors, rarely studied nowadays, 
should have a role in causing NCWS. AGA, anti-gliadin antibody; BAT, 
basophil activation test; CD, celiac disease; DBPC, double-blind placebo-
controlled; EmA, endomysial antibody; EOS, eosinophils; FODMAP, 
fermentable oligo-, di-, and mono-saccharides and polyols; IEL, intraepitheli-
al lymphocyte; IgG, immunoglobulin G; NCWS, non-celiac wheat sensitivity. 
exclude a CD diagnosis in patients who self-report symptoms 
related to wheat ingestion. The presence of duodenal villi 
atrophy cannot be considered mandatory for CD diagnosis, 
although it is still included in the current diagnostic crite-
ria for adult patients. It has been demonstrated that serum 
anti-endomysial-positive patients with an initial evaluation of 
normal duodenal histology had symptom resolution on gluten-
free diet, and they eventually developed duodenal villi atrophy 
on gluten-containing diet ( 51,52 ). The objection that these 
CD patients tested positive for serum CD-specific antibod-
ies (anti-transglutaminase and anti-endomysium), whereas 
NCWS must be negative by definition, could be disregarded 
considering that in a very initial phase of CD the specific anti-
bodies can be detected only in the intestinal mucosa, the site 
of their production, and not in the serum ( 53,54 ). Despite the 
negative serum anti-transglutaminase and anti-endomysium 
assays and the absence of villous atrophy, we demonstrated 
that symptomatic patients who produced anti-endomysium in 
the duodenal culture can subsequently develop villous atrophy 
when remaining on a gluten-containing diet ( 55 ). In our recent 
study, anti-endomysium production in duodenal culture was 
found in 22 of 276 (8 % ) patients diagnosed with NCWS, thus 
not showing villi atrophy and positive serum antibodies ( 7 ). It 
is possible that future diagnostic criteria for CD will include 
these patients. 
 Other pathogenic mechanisms, even if not immune-mediated, 
should be considered. For example, it is possible that the non-pro-
tein component of wheat might be responsible for symptoms. Th e 
fermentable fructans could cause IBS-like symptoms ( 6 ), and it 
has been demonstrated that fermentable oligo-, di-, and mono-
saccharides and polyols may cause symptoms, which over-
lap with IBS ( 56 ). A wheat-free diet may be useful in these 
patients, as it reduces the amount of the short-chain carbo-
hydrates present in processed grains and cereals ( 57 ). Th is 
hypothesis was recently further supported by a study, which 
demonstrated that in self-reported NCWS patients the gas-
trointestinal symptoms signifi cantly improved during reduced 
fermentable oligo-, di-, and mono-saccharides and polyols intake, 
but signifi cantly worsened to a similar degree when their diets 
included gluten or whey protein. Th is study did not show gluten-
specifi c gastrointestinal eff ects ( 58 ). However, it should be noted 
that the patients included in that study were not representative of 
NCWS as all subjects with duodenal lymphocitosis (Marsh 1) were 
excluded and most of the NCWS patients included in other stud-
ies showed a Marsh 1 histology. Also the use of whey proteins as 
placebo could be confounding as we had demonstrated a very high 
frequency of NCWS associated with CM protein hype rsensitivity ( 7 ). 
 A change in diet with wheat withdrawal can also cause a change 
in the intestinal microbiota. Th is is now considered a crucial ele-
ment in IBS pathogenesis ( 59 ). Future studies in NCWS patients 
should also consider the role of diet in the microbiota and, in 
turn, on the intestinal immune system. In an animal model, Verd ù 
 et al. ( 60 ) showed that mice sensitized to gliadin displayed intrinsic 
muscle hypercontractility associated with increased release of ace-
tylcholine from the myenteric plexus. Th is fi nding was associated 
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 In conclusion, NCWS can now be considered the cause of gas-
trointestinal symptoms, which overlap those commonly attrib-
uted to functional disorders. However, many doubts remain and 
it must be underlined that we must utilize the DBPC challenge 
method to confi rm the suspicion of NCWS and then study the 
pathogenesis of that specifi c clinical manifestation. A confi dent 
NCWS diagnosis must exclude a placebo eff ect. In our opinion, 
NCWS is a heterogeneous condition, which includes diff erent 
subgroups of patients ( Figure 1 ). We suggest that the patients 
suff ering from NCWS alone are probably diff erent from those 
suff ering from multiple food sensitivity. Th is latter group of 
patients is more numerous, including a number of cases three-
fold greater than the patients suff ering from wheat sensitivity 
alone. Th e patients with NCWS and multiple food sensitivity 
show several clinical, laboratory, and histology characteristics, 
which suggest that they might suff er from non-IgE-mediated 
food allergy. Future studies on the pathogenic mechanisms of 
this form of NCWS will clarify whether  “ NCWS ” can be replaced 
by the shorter  “ wheat hypersensitivity ” . 
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